Hypertension, Pulmonary

Showing 51 - 75 of 138

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hypertension, Pulmonary Trial in London (Actigraph GT9X Link device)

Terminated
  • Hypertension, Pulmonary
  • Actigraph GT9X Link device
  • London, United Kingdom
    Hammersmith Hospital
Jul 10, 2019

Hypertension, Pulmonary, Diseases of Mitral Valve Trial (Sildenafil, Placebo)

Terminated
  • Hypertension, Pulmonary
  • Diseases of Mitral Valve
  • (no location specified)
Jul 2, 2019

RiociguaT in Patients With Pulmonary Hypertension

Completed
  • Hypertension, Pulmonary
  • Riociguat (Adempas, BAY63-2521)
  • Multiple Locations, Argentina
  • +27 more
Jun 18, 2019

Preference in Pulmonary Arterial Hypertension (PAH) Subjects

Completed
  • Hypertension, Pulmonary
  • Telephone concept elicitation interview
  • Boston, Massachusetts
    GSK Investigational Site
Mar 29, 2019

Inhaled Treatment With Ventavis in Pulmonary Hypertension

Completed
  • Hypertension, Pulmonary
  • Iloprost (Ventavis, BAYQ6256)
  • Multiple Locations, Russian Federation
    (unnamed)
Mar 25, 2019

Hypertension, Pulmonary Trial in Worldwide (Riociguat (Adempas, BAY63-2521))

Completed
  • Hypertension, Pulmonary
  • Riociguat (Adempas, BAY63-2521)
  • La Jolla, California
  • +26 more
Feb 20, 2019

Hypertension, Pulmonary Trial in London (FDC (ambrisentan 10 mg-tadalafil 40 mg) single dose, Reference (ambrisentan 10 mg +

Completed
  • Hypertension, Pulmonary
  • FDC (ambrisentan 10 mg-tadalafil 40 mg) single dose
  • Reference (ambrisentan 10 mg + tadalafil 40 mg given concurrently)
  • London, United Kingdom
    GSK Investigational Site
Jul 31, 2018

Hypertension, Pulmonary Trial in London ([11C]-GSK2256098 500 MBq)

Completed
  • Hypertension, Pulmonary
  • [11C]-GSK2256098 500 MBq
  • London, United Kingdom
  • +1 more
Oct 15, 2018

The Exercise Capacity and Quality of Life in IPAH and Secondary

Completed
  • Hypertension, Pulmonary
    • Taipei, Zhongzheng Dist, Taiwan
      National Taiwan University Hospital
    Jul 10, 2018

    Heart Diseases, Hypertension, Pulmonary Trial in Worldwide (tezosentan, )

    Terminated
    • Heart Diseases
    • Hypertension, Pulmonary
    • Stanford, California
    • +32 more
    Jul 6, 2018

    First-line Bosentan and Sildenafil Combination Therapy for

    Completed
    • Hypertension, Pulmonary
      • Calgary, Alberta, Canada
        University of Calgary, Peter Lougheed Hospital
      Jun 9, 2018

      Hypertension, Pulmonary, Heart Failure Trial in Mountain View (Preventing pulm HTN during exercise)

      Unknown status
      • Hypertension, Pulmonary
      • Heart Failure
      • Preventing pulm HTN during exercise
      • Mountain View, California
        El Camino Hospital
      Apr 5, 2018

      Pilot in Pulmonary Hypertension

      Completed
      • Hypertension, Pulmonary
      • Correlation assessment
      • Multiple Locations, Canada
        (unnamed)
      Dec 19, 2017

      Hypertension, Pulmonary Trial in Japan (Iloprost (Ventavis inhaled, BAYQ6256))

      Completed
      • Hypertension, Pulmonary
      • Iloprost (Ventavis inhaled, BAYQ6256)
      • Nagoya, Aichi, Japan
      • +17 more
      Dec 6, 2017

      Alveolitis, Fibrosing, Fibrosis, Pulmonary, Hypertension, Pulmonary Trial in Miami (sildenafil)

      Completed
      • Alveolitis, Fibrosing
      • +2 more
      • Miami, Florida
        VA Medical Center, Miami
      Sep 29, 2017

      Hypertension, Pulmonary Trial in Worldwide (PF-00489791, , sildenafil)

      Terminated
      • Hypertension, Pulmonary
      • Phoenix, Arizona
      • +24 more
      Sep 20, 2017

      Hypertension, Pulmonary Trial in Canada, Netherlands, United States (current marketed FLOLAN (epoprostenol sodium), new thermo

      Completed
      • Hypertension, Pulmonary
      • current marketed FLOLAN (epoprostenol sodium)
      • new thermo stable formulation of epoprostenol sodium
      • Miami Beach, Florida
      • +7 more
      Sep 13, 2017

      Hypertension, Pulmonary Trial in Puerto Rico, United States (Riociguat (Adempas, BAY63-2521))

      Completed
      • Hypertension, Pulmonary
      • Riociguat (Adempas, BAY63-2521)
      • Tucson, Arizona
      • +58 more
      Sep 12, 2017

      Infant, Newborn, Hypertension, Pulmonary, Persistent Fetal Circulation Syndrome Trial in United States (Inhaled Nitric Oxide,

      Terminated
      • Infant, Newborn
      • +5 more
      • Inhaled Nitric Oxide
      • Standard iNO therapy
      • Birmingham, Alabama
      • +17 more
      Sep 22, 2017

      Infant, Newborn, Hypertension, Pulmonary, Persistent Fetal Circulation Syndrome Trial in Canada, United States (Inhaled nitric

      Terminated
      • Infant, Newborn
      • +5 more
      • Inhaled nitric oxide
      • Placebo
      • Palo Alto, California
      • +19 more
      Sep 22, 2017

      Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age Trial in United States (Inhaled nitric oxide,

      Terminated
      • Infant, Newborn
      • +7 more
      • Inhaled nitric oxide
      • Placebo
      • Birmingham, Alabama
      • +16 more
      Sep 22, 2017

      Hypertension, Pulmonary Trial in Worldwide (ambrisentan, tadalafil)

      Completed
      • Hypertension, Pulmonary
      • Birmingham, Alabama
      • +142 more
      Aug 14, 2017

      Hypertension, Pulmonary Trial in United States (Simvastatin, Aspirin, Placebo)

      Terminated
      • Hypertension, Pulmonary
      • Baltimore, Maryland
      • +3 more
      Jul 18, 2017

      Hypertension, Pulmonary Trial in Chicago (Carbon Monoxide)

      Withdrawn
      • Hypertension, Pulmonary
      • Carbon Monoxide
      • Chicago, Illinois
        University of Illinois at Chicago Medical Center
      Jun 8, 2017

      Hypertension, Pulmonary Trial in Stanford, Chicago (treprostinil inhalations, tadalafil)

      Completed
      • Hypertension, Pulmonary
      • Stanford, California
      • +1 more
      Apr 27, 2017